e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea
Barceló A., Piérola J., de la Peña M., Esquinas C., Fuster A., Sanchez-de-la-Torre M., Carrera M., Alonso-Fernandez A., Ladaria A., Bosch M., Barbé F.
Source:
Eur Respir J 2011; 37: 1418-1423
Journal Issue:
June
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Barceló A., Piérola J., de la Peña M., Esquinas C., Fuster A., Sanchez-de-la-Torre M., Carrera M., Alonso-Fernandez A., Ladaria A., Bosch M., Barbé F.. Free fatty acids and the metabolic syndrome in patients with obstructive sleep apnoea. Eur Respir J 2011; 37: 1418-1423
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
PERIPHERAL ARTERIAL TONOMETRY AND INTIMA MEDIA THICKNESS IN OBSTRUCTIVE SLEEP APNEA.
Related content which might interest you:
Free fatty acids levels and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2010 - Obesity: positive effects of bariatric surgery and exercise
Year: 2010
Increased risk of obstructive sleep apnoea in patients with non-alcoholic fatty liver disease
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA II
Year: 2012
Association between obstructive sleep apnea and nonalcoholic fatty liver disease
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019
The impact of severe obstructive sleep apnea and obesity on nonalcoholic fatty liver disease.
Source: International Congress 2017 – Obstructive and central sleep apnoea: consequences and comorbidities
Year: 2017
Association between obstructive sleep apnea and the severity of non-alcoholic fatty liver disease.
Source: International Congress 2019 – Impact of sleep-disordered breathing in other diseases
Year: 2019
Diabetes and metabolic aspects of OSA
Source: Eur Respir Mon 2010; 50: 189-215
Year: 2010
The relationship between uric acid levels and mean platelet volume and metabolic syndrome in males with with obstructive sleep apnoea syndrome
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012
Metabolic syndrome in obstructive sleep apnoea patients
Source: Annual Congress 2007 - Sleep apnoea
Year: 2007
Glucose metabolism abnormalities in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I
Year: 2012
Metabolic syndrome in obstructive sleep apnea: prevalence and correlation with metabolic abnormalities
Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing
Year: 2009
Metabolic syndrome in obstructive sleep apnea: prevalence and correlation with metabolic abnormalities
Source: Annual Congress 2008 - Metabolic syndrome and systemic inflammation in obstructive sleep apnoea
Year: 2008
Obstructive sleep apnoea and metabolic impairment in severe obesity
Source: Eur Respir J 2011; 38: 1089-1097
Year: 2011
Could obstructive sleep apnea syndrome be a component of metabolic syndrome?
Source: Eur Respir J 2006; 28: Suppl. 50, 414s
Year: 2006
The influence on hyperlipemia and abnormal glucose metabolism in obstructive sleep apnea-hypopnea syndrome (OSAHS)
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
Frequency and importance of metabolic syndrome in obstructive sleep apnea syndrome
Source: Eur Respir J 2006; 28: Suppl. 50, 414s
Year: 2006
Effect of arterial hypertension, obesity and overnight desaturation on plasma uric acid concentration in obstructive sleep apnoea (OSA) patients
Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA
Year: 2012
Prevalence of the metabolic syndrome in untreated Mediterranean patients with the obstructive sleep apnea syndrome (OSAS)
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Predictors of obstructive sleep apnea syndrome and metabolic syndrome
Source: Annual Congress 2011 - Obstructive sleep apnoea: inflammation and metabolism
Year: 2011
Cardiovascular risk, insulin resistance and metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
What constituents of the metabolic syndrome are prevalent in the sleep apnoea syndrome?
Source: Eur Respir J 2005; 26: Suppl. 49, 568s
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept